Gene4331
MNAT1: MNAT1 component of CDK activating kinase
Cite this record
ConductScience Library. MNAT1: MNAT1 component of CDK activating kinase. Genes, record 4331. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/4331
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P51948 | CDK-activating kinase assembly factor MAT1 | 309 | 67 | Ensembl, GeneID, HGNC |
Source UniProt
Patents62
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 1860 | P51948 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 1860 | P51948 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1860 | P51948 | Espacenet |
| US 20250074962 A1 | 2025-03-06 | 6953 | P51948 | Espacenet |
| US 20250002924 A1 | 2025-01-02 | 188 | P51948 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 30638 | P51948 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 6953 | P51948 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 128327 | P51948 | Espacenet |
| US 12049633 B2 | 2024-07-30 | 188 | P51948 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 52737 | P51948 | Espacenet |
NIH grants575
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MNAT1 papers | Newest fiscal year |
|---|---|---|---|
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 9 | 2025 |
| R35GM127018 | Structural studies of function and regulation of microtubules and transcriptional gene expression machinery | 5 | 2025 |
| R35CA220430 | Mesoscale and Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC) | 4 | 2025 |
| R35GM139550 | Mechanisms of RNA polymerase II transcription regulation | 4 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 3 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 3 | 2025 |
| R01CA218315 | The XPA scaffold protein in Nucleotide Excision Repair | 3 | 2025 |
| R01GM123233 | Functional and structural studies of the transition from transcription initiation to elongation | 3 | 2025 |
| R35GM127289 | Cyclin-dependent kinase control of cell-division and transcription cycles | 3 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
Source NIH's project files
Papers787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MNAT1 in gastrointestinal cancers: mechanistic insights and therapeutic strategies-a narrative review. | J Gastrointest Oncol | 2026 | 42703445 | PubTator, text mining | PubMed |
| Integrating Structural, Biochemical, and Cellular Perspectives on the TFIIH Helicases XPB and XPD. | Biomolecules | 2026 | 41897370 | PubTator, text mining | PubMed |
| Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity. | Leukemia | 2026 | 41882098 | PubTator, text mining | PubMed |
| Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | 41710088 | PubTator, text mining | PubMed |
| The cyclin dependent kinase (CDK)7 inhibitor BS-181 inhibits pathogenic Cryptococcus species, causing G2/M arrest and a splicing defect. | Virulence | 2026 | 41701636 | PubTator, text mining | PubMed |
| Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. | Mol Biomed | 2026 | 41692895 | PubTator, text mining | PubMed |
| Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC. | Front Immunol | 2025 | 41235252 | PubTator, text mining | PubMed |
| Structural basis of T-loop-independent recognition and activation of CDKs by the CDK-activating kinase. | Science | 2025 | 41100585 | Swiss-Prot, curated | PubMed |
| Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction. | bioRxiv | 2025 | 40949955 | PubTator, text mining | PubMed |
| Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics. | Nat Commun | 2025 | 40835825 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4331
GET https://conductscience.org/api/genes/v1/4331/patents?page=2